Results of interferon treatment in chronic hepatitis B;Kronik B hepatitinde interferon tedavisi ile elde edilen sonuclar

Gulhane Medical Journal

Volumn 42, Issue 3, 2000, Pages 219-224

  Uygun, A ^a   Bagci, S ^a   Dogru, T ^a   Erdil, A ^a   Deveci, S ^a   Guney, C ^a   Gulsen, M ^a   Karaeren, N ^a   Dagalp, K ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic Hepatitis B; Interferon Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERFERON; VIRUS DNA;

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC HEPATITIS; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; MALE; RECURRENT INFECTION; RETROSPECTIVE STUDY; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0033777356     PISSN: 13020471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Therapy of chronic viral hepatitis
2. Current therapeutic trends in therapy for chronic viral hepatitis
3. Effect of alfa interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B. A meta analysis
4. Prednisone-interferon combination in the treatment of chronic hepatitis B: Direct and indirect meta-analysis
5. A randomized controlled trial of recombinant alpha interferon therapy for chronic hepatitis B
6. The treatment of chronic viral hepatitis
7. Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B
8. Long-term remission of chronic hepatitis B after alfa interferon therapy
9. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy
10. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa
11. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
12. Interferon alfa for chronic active hepatitis B. Long-term follow-up of 62 patients: Outcomes and predictors of response
13. Kronik viral hepatitlerde alfa interferon tedavisinin histolojik iyilesme uzerine etkisi
14. Kronik viral hepatit B ve C'nin tedavisinde alfa- 2a interferonun etkinligi
15. Kronik Hepatit B Infeksiyonunda Interferon Tedavisine Cevabin Degerlendirilmesi
16. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy
17. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B
18. Hepatitis B virus precore/core variation and interferon therapy
19. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha
20. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance
21. Core Promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B
22. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus IFNection: A prospective study
23. Delayed HBsAg clearance in chronic hepatitis B viral IFNection
24. Long-term follow-up in a randomised controlled trial of recombinant a-interferon in Chinese patients with chronic hepatitis B IFNection
25. Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: A randomized controlled trial
26. Loss of HBsAg with interferon therapy in chronic hepatitis B virus IFNection
27. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B
28. Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen
29. Natural history and prognostic factors for chronic hepatitis B